Navigation Links
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting

to apply its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics, applications of Sangamo's ZFP TF technology platform and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, uncertainties relating to the initiation and completion of stages of ZFP Therapeutic clinical trials, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.

CONTACT: Elizabeth Wolffe, Ph.D., Sangamo BioSciences, Inc.,+1-510-970-6000, ext. 271, or ; or Justin Jackson(media), Burns McClellan, Inc., +1-212-213-0006, or ewolffe@sangamo.com jjackson@burnsmc.com

Web site: http://www.sangamo.com//

Ticker Symbol: (NASDAQ-NMS:SGMO)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on ... reported positive top-line clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes. The ... States under a U.S. Food and ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms of ... or unnoticed, but new technology, coupled with yearly, ... leading to earlier detection of eye diseases, including ... million Americans. If left untreated, these diseases can ... Recently, optometric researchers have deployed ...
(Date:10/22/2014)... , Oct. 21, 2014 Influenza will affect as ... in the United States as high ... thought to spread is from person to person in respiratory ... a serve way of death, but kills much fewer people ... also done by human fluids including sweat, saliva, blood and ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2
...  SL Industries, Inc. (Amex: SLI ) ("SLI" or ... named Chief Financial Officer, Secretary, and Treasurer of the Company, ... promote Lou to the CFO position at SLI," said William ... a key member of the SLI management team in his ...
... ranked first place as an industry leader in the ... on the Pittsburgh Business Times Top 100 list, which ... With a growth rate of 847% since 2007, Precision ... by recently hiring 100 new employees and raising $35 ...
Cached Medicine Technology:SL Industries Names Louis J. Belardi Chief Financial Officer 2Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100 2
(Date:10/22/2014)... Viejo, CA (PRWEB) October 22, 2014 ... Jay Cormier, Sr. Vice President of Sales, will be ... the upcoming Meetings Technology Expo on October 28, at ... also be hosting a booth as well as a ... how Lintelus Meeting can create a more engaging event ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... only about half as likely as white women to become ... and the racial disparity persists even when donor eggs are ... patients became pregnant after IVF, compared to about 17 percent ... over two years to tease out the impact of race, ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
(Date:10/20/2014)... With a mere 19 days to November 4, ... fundraising stop at the  Law Offices of Dan ... debate last night with his opponent Gov. Rick Scott, ... seven minutes because Crist had an electric fan underneath ... one word: "weird." , Before touching on his well-known ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, ... Columbus, Inc., A Division of MaternOhio Clinical Associates, Inc., ... 100,000 patients annually. Dr. Murphy will provide a full ... a women’s life. She is accepting new patients at ... Dublin. , Dr. Murphy offers a wide variety of ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
... ... upper extremity range, bebionic. Launched at the ISPO World congress in May, the new myo-electric ... Euros, or $11,000 USD. , ... (PRWeb UK) July 1, 2010 -- RSLSteeper have announced the pricing for the bebionic hand, ...
... HealthDay Reporter , THURSDAY, July 1 (HealthDay News) ... the path to recovery may be even harder -- and ... for adults, experts say. "Disorders that start when you,re ... harder to treat and harder to recover from," said Dr. ...
... could understand why cancer develops? We know that certain risk factors, ... of developing this terrible disease, but cancer can form in any ... that has emerged is that for a cell to transform into ... affecting different genes needed to control cell growth. In a study ...
... life appears to diminish brain function in older adulthood, according ... that has implications for many poor, developing nations. The ... that fighting hunger throughout childhood not only saves lives and ... life. The study appears in the journal Social Science ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, July ... and CSI may not be good for seniors, mental ... Americans ages 15 to 98 and found that adults over age ... TV than younger adults. But while the younger ...
... ... Approved Seal by PTPA Media. PTPA Media (Parent Tested, Parent Approved) awards their industry-renowned seal ... life and worthy of a parent’s recommendation. , ... (PRWEB) July 1, 2010 -- The Good Nite Lite has ...
Cached Medicine News:Health News:RSLSteeper announces pricing for new bionic hand 2Health News:Eating Disorders, Addictions Tough to Treat in Teens 2Health News:Eating Disorders, Addictions Tough to Treat in Teens 3Health News:Eating Disorders, Addictions Tough to Treat in Teens 4Health News:DNA mutation rates raise curtain on cause of cancer 2Health News:DNA mutation rates raise curtain on cause of cancer 3Health News:Childhood malnutrition could weaken brain function in elderly 2Health News:Older Folks Watch More TV, Get Less Out of It 2Health News:Older Folks Watch More TV, Get Less Out of It 3Health News:The Good Nite Lite Awarded the Parent Tested Parent Approved Seal 2
... your patients' electronic medical records ... As a Web-enabled software application, ... up a patient's cardiology and ... hospital intranet. CardioChart displays patient ...
... CardioDoc™ produces patient care reports for ... automated physician reporting and documentation tool, ... diagnostics, images, H&P, labs, medications, and ... completed, signed with an e-signature, and ...
... specific EMR / PM system is ... more effective patient care decisions.,AcerMed's system ... with critical information on a real,time ... Cardiology specific clinical pathways have been ...
...
Medicine Products: